QCM Cayman’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

QCM Cayman’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,157	Closed	-$50K	–	187
2021 Q1	$50K	Buy	+2,157	New	+$54.6K	0.15%	98

Other funds holding VYNT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Blankinship & Foster Solana Beach, California $452M AUM 16.63% 1-Year Est. Return

FWM

Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

TWMP

Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QCM Cayman's VYNT Position: Q2 2021 in Review

QCM Cayman sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2021, closing a stake of 2,157 shares — an estimated $50K sold.

QCM Cayman first reported a position in VYNT in Q1 2021 and held it in 1 quarter. The position peaked at $50K in Q1 2021. 29 funds tracked by Wall St. Rank hold VYNT as of Q2 2021.

QCM Cayman reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
QCM Cayman sold 2,157 Vyant Bio, Inc. Common Stock shares in Q2 2021, an estimated $50K.
QCM Cayman first reported a position in Vyant Bio, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
QCM Cayman's Vyant Bio, Inc. Common Stock position peaked at $50K in Q1 2021.
29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2021.

Based on QCM Cayman's 13F filing for Q2 2021, filed 10 Aug 2021.